United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$417.57 USD
+7.70 (1.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $419.09 +1.52 (0.36%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
United Therapeutics Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
UTHR 417.57 +7.70(1.88%)
Will UTHR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for UTHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UTHR
Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?
Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
Other News for UTHR
UTHR makes New 52 Week Closing High on September 19
Director’s Major Stock Sale at United Therapeutics!
UTHR forms Golden Cross on September 18
Insider Sell: Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
UTHR forms 180 Bullish Setup on September 17